Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NeuroNexus Technologies Inc.

Division of Nuvectra Corp.
www.neuronexustech.com

Latest From Oncology Venture APS

Deal Watch: Gilead And Spring Bank Set Second Trial Collaboration In HBV

Analyst speculates that Gilead could move to acquire Spring Bank if combo trial yields promising data for functional cure of hepatitis B. Eisai in-licenses PARP inhibitor with potential in breast cancer from Oncology Venture, while Sunovion out-licenses three corticosteroid products to Covis.

Deals Commercial
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Monitoring Equipment & Devices
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
  • Therapeutic Areas
  • Cardiovascular
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Nuvectra Corp.
  • Senior Management
  • Daryl Kipke, PhD, Pres. & CEO
    Kc Kong, Dir., Sales & Mktg.
    Linda Thompson, Dir., Fin. & Admin.
  • Contact Info
  • NeuroNexus Technologies Inc.
    Phone: (734) 913-8858
    655 Fairfield Ct.
    Ste. 100
    Ann Arbor, MI 48108
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register